Target intelligence / Profile preview

Class 1 outer membrane protein PorA (P1.4) (PorA P1.4)

Target
PorA P1.4
Molecular classification
Outer membrane protein, Porin, Transmembrane protein, Bacterial antigen
01

Overview

Outer membrane protein PorA (P1.4) is a major surface-exposed protein of Neisseria meningitidis, the bacterium responsible for invasive meningococcal disease, including meningitis and sepsis [1, 6]. It functions as a cation-selective porin, forming trimeric channels in the outer membrane that facilitate the transport of small molecules and nutrients [6]. The P1.4 designation refers to a specific serosubtype defined by the sequence of its variable regions (VR1 and VR2), which are the primary targets for host immune responses [8]. Due to its high immunogenicity, PorA P1.4 is a critical component of several meningococcal B vaccines, such as Bexsero and MeNZB, where it is typically presented within outer membrane vesicles (OMVs) [2, 4]. These vaccines work by inducing bactericidal antibodies that trigger complement-mediated killing of the bacteria [4, 7]. However, the effectiveness of PorA-targeted therapies is challenged by the protein's high degree of antigenic variation and phase variation, which allow the bacteria to escape immune detection [1, 8]. Consequently, PorA-based protection is often strain-specific, necessitating the inclusion of multiple antigens in modern vaccine formulations [4, 13].

Other names
Porin AP1.4PorA P1.7-2,4Class 1 OMPOuter membrane protein PorA
02

Mechanism of action

Induction of host bactericidal antibodies that recognize the PorA protein on the bacterial surface, triggering the classical complement pathway and resulting in complement-mediated lysis and opsonophagocytosis of Neisseria meningitidis [4, 7].

03

Biological functions

Cation-selective pore formationNutrient transportImmune evasionStructural integrity
04

Disease associations

Invasive meningococcal diseaseMeningitisSepsis
05

Safety considerations

Antigenic variationPhase variationStrain-specific protectionLocal and systemic vaccine reactions (e.g., fever, pain) [1, 3, 8]
06

Interacting drugs

Bexsero (4CMenB)

1 more in the full profile.

07

Biomarkers

Serum bactericidal assay (hSBA) titerMeningococcal Antigen Typing System (MATS) [4, 7, 13]

Beyond the preview

Go deeper on Class 1 outer membrane protein PorA (P1.4) (PorA P1.4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Class 1 outer membrane protein PorA (P1.4) (PorA P1.4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call